Risks of oral anticoagulants: Analysis of adverse drug reactions reported to the Portuguese National Pharmacovigilance System
Abstract Cardiovascular diseases are the leading cause of death globally, making the use of oral anticoagulants for prevention increasingly important. Historically, warfarin has played a significant role in this context. In recent years, introduction of new oral anticoagulants, such as rivaroxaban,...
Saved in:
| Main Authors: | Ana Sofia Martins, Cristina Monteiro, Ana Paula Duarte |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-10-01
|
| Series: | Pharmacology Research & Perspectives |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/prp2.1235 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intracardiac thrombosis: frequency, risk factors and place of oral anticoagulants in treatment
by: E. S. Kropacheva
Published: (2020-06-01) -
Nephrotic Syndrome Thromboprophylaxis With Direct Oral Anticoagulants or Vitamin K Antagonists
by: Edouard Cubilier, et al.
Published: (2025-05-01) -
Prothrombin complex concentrate for reversal of oral anticoagulants in patients with oral anticoagulation-related critical bleeding: a systematic review of randomised clinical trials
by: Christian Ovesen, et al.
Published: (2025-02-01) -
Ischemic Stroke in Patients Under Oral Anticoagulation: The Achilles Heel of Atrial Fibrillation Management
by: Kyriakos Dimitriadis, et al.
Published: (2025-04-01) -
A new strategy for monitoring of direct oral anticoagulants in patients with cyanotic and complex congenital heart disease
by: Fabienne Dirbach, et al.
Published: (2024-12-01)